The webmaster of Influenza Virus Net, D.A. Bleijs, PhD, has a scientific background in molecular biology and immunology. Since several years, he is involved as a policy officer in the clinical trial assessment procedure in the Netherlands. The webmaster is also owner and creator of Gene Therapy Net, Dengue Virus Net, Ebola Virus Net, Corona Virus Net and Chikungunya Virus Net. Influenza Virus Net is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about dengue.
Influenza Virus Net is intended to be informative for professionals, doctors and researchers, as well as for students, patients, regulatory affairs officers, government policy officers, and everyone else interested in influenza.
Please use the contact form for any questions or remarks.
Influenza Virus Net may link users to sites not maintained by Influenza Virus Net. Influenza Virus Net cannot and does not warrant the accuracy, completeness, timeliness, non-infringement, merchantability or fitness for a particular purpose of any information available through these links and disclaims any opinions expressed on such sites. The information in Influenza Virus Net is provided with no guarantee of completeness, accuracy, and timeliness or of the results obtained from the use of this information. Influenza Virus Net accepts no responsibility for any deviations, errors or omissions in information on this site.
Influenza Virus Net respects the privacy of your personal information. Any information collected will be kept strictly confidential and will not be sold, rented, loaned or otherwise disclosed.
Influenza Virus Net collects information about their visitors in order to gather statistics about the number of visitors, the most and least popular pages on the site, where there may be problems in serving certain pages to visitors, etc. Please note, however, that Influenza Virus Net has no interest in personally identifying its users. The only thing that Influenza Virus Net is interested in is the overall statistics of its readership.